Document:

<PAGE>
                                                                    EXHIBIT 4(d)

                               AMENDMENT AGREEMENT

                  THIS AMENDMENT AGREEMENT, dated as of November 21, 2001 (this
"Agreement"), by and among LIFEPOINT, INC., a Delaware corporation, and each of
the holders of shares of the Company's Series C Convertible Preferred Stock,
$.001 par value (the "Series C Preferred Stock"), named on the signature pages
hereto (each, a "Holder", and collectively, the "Holders").

                              W I T N E S S E T H:

                  WHEREAS, pursuant to the Securities Purchase Agreement, dated
as of June 20, 2001, between the Company and the Holders, the Company has issued
and sold to the several Holders an aggregate of 393,916 shares of Series C
Preferred Stock, and in connection therewith the Company and the Holders entered
into a Registration Rights Agreement, dated as of June 20, 2001 (the
"Registration Rights Agreement");

                  WHEREAS, pursuant to the Amendment, dated as of August 16,
2001 (the "First Amendment"), the Company and all of the Holders of shares of
Series C Preferred Stock amended certain terms of the Securities Purchase
Agreement, the Registration Rights Agreement and the Warrants issued pursuant to
the Securities Purchase Agreement and the Company agreed, subject to stockholder
approval, to amend the Certificate of Designation to reduce the initial
conversion price of the Series C Preferred Stock to $3.00 per share of Common
Stock issued upon conversion thereof; and

                  WHEREAS, upon the terms and subject to the conditions of this
Agreement, the Company and the Holders wish to amend further the rights of the
Holders relating to the Series C Preferred Stock;

                  NOW THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

                  1. AMENDMENTS.

                  (a) FIRST AMENDMENT. The provisions of the First Amendment
which would require the Company, if it has not, on or before October 18, 2001
(as extended by waivers from Holders), obtained the approval by its stockholders
of the amendments of the Certificate of Designation specified in the First
Amendment, to offer to issue shares of Series D Convertible Preferred Stock,
$.001 par value, in exchange for shares of Series C Preferred Stock, are hereby
deleted in their entirety.

                  (b) REGISTRATION RIGHTS AGREEMENT. The Registration Rights
Agreement is hereby amended as follows:

                                       1
<PAGE>
                  (1) The definition of the term "Registration Default" in
Section 2(c) of the Registration Rights Agreement is hereby amended to delete
(i), renumber (ii) as (i) and (iii) as (ii) and add the following at the end
thereof:

         ", or (iii) the Company fails to file the Registration Statement
         (excluding for this purpose Registration Statement No. 333-65540,
         which was withdrawn effective September 27, 2001) with the SEC,
         covering at least the Registrable Securities underlying outstanding
         shares of Series C Preferred Stock and Warrants which are not held in
         escrow pursuant to the Escrow Agreement, on or before November 29, 2001
         (the "Non-Escrow Registration Statement"), or (iv) the Non-Escrow
         Registration Statement is not declared effective by the SEC on or
         before December 31, 2001, or (v) the Company fails to file the
         Registration Statement (excluding for this purpose Registration
         Statement No. 333-65540) with the SEC, covering the Registrable
         Securities underlying outstanding shares of Series C Preferred Stock
         and Warrants which are held in escrow pursuant to the Escrow Agreement
         at the time the Non-Escrow Registration Statement is filed with the
         SEC, on or before the date which is 30 days after the date such shares
         of Series C Preferred Stock and Warrants are released from the escrow
         under the Escrow Agreement to the Holders entitled thereto (the "Escrow
         Registration Statement"), or (vi) the Escrow Registration Statement is
         not declared effective by the SEC on or before the date which is 60
         days after the date such shares of Series C Preferred Stock and
         Warrants are released from the escrow under the Escrow Agreement to the
         Holders entitled thereto"

                  (2) The definition of the term "Registration Statement" is
hereby amended to include the Non-Escrow Registration Statement and the Escrow
Registration Statement or Statements.

                  (3) The provisions of Section 2(c) of the Registration Rights
Agreement are hereby amended to add the following:

                  (A) For purposes of determining the amount of any payment
         pursuant to Section 2(c) of the Registration Rights Agreement that is
         payable by the Company to a particular Investor by reason of a
         Registration Default specified in clause (iii) or clause (iv) of the
         definition of such term, the Aggregate Share Price shall be the
         aggregate Purchase Price of the Series C Preferred Stock and Warrants
         of such Investor which shares and Warrants are not held in escrow
         pursuant to the Escrow Agreement at the time the Non-Escrow
         Registration Statement is filed with the SEC; and

                  (B) For purposes of determining the amount of any payment
         pursuant to Section 2(c) of the Registration Rights Agreement that is
         payable by the Company to a particular investor by reason of a
         Registration Default specified in clause (v) or clause (vi) of the
         definition of such term, the Aggregate Share Price shall be the
         aggregate Purchase Price of the Series C Preferred Stock and Warrants
         of such Investor which shares and Warrants are held in escrow pursuant
         to the Escrow Agreement at the time the Non-Escrow Registration
         Statement is filed with the SEC and which are released from such escrow
         by reason of satisfaction of Section 4(a) or (b) of the Escrow
         Agreement, as the case may be.

                                       2
<PAGE>
                  (4) Notwithstanding Section 2(c) of the Registration Rights
Agreement, any obligation of the Company to pay any amount pursuant to such
Section 2(c) may be satisfied by the Company by delivery to the Holder entitled
to such payment, on or before the due date for such payment, of a number of
shares of Common Stock equal to the quotient obtained by dividing (x) the amount
of such payment, expressed in dollars, by (y) the lesser of (i) the conversion
price in effect under Section 2 of this Agreement at the time such payment is
due and (ii) the average closing bid price of the Common Stock for the five
Trading Days ending on and including the Trading Day immediately preceding the
due date for such payment. The Company may exercise its right to satisfy such
payment obligations with shares of Common Stock only by giving written notice of
such election to the Holder entitled to such payment not less than seven Trading
Days prior to the due date for such payment. The shares deliverable by the
Company in satisfaction of its obligations to make such payments shall be
Registrable Securities for purposes of the Registration Rights Agreement. The
Company may satisfy such payment obligations with shares of Common Stock only to
the extent the resale of such shares by the Holders (1) is covered by the
Registration Statement and the Registration Statement is effective and available
for use by the recipient of such shares at the time the Company delivers such
shares or (2) the Registration Statement covering such shares has been filed
with the SEC and is the Registration Statement of which the failure to file or
become effective is the basis on which the Company has become obligated to make
the payment that is being satisfied by the Company's delivery of such shares.

                  2. RIGHT TO CONVERT SERIES C PREFERRED STOCK.

                  (a) In addition to the right to convert shares of Series C
Preferred Stock into Common Stock pursuant to the Certificate of Designation,
the Holders and each person who from time to time is a holder of record of
outstanding shares of Series C Preferred Stock shall have the right to convert
such shares with the Company in whole at any time or in part from time to time
into fully paid and nonassessable shares of Common Stock on the basis provided
in this Agreement. Any such conversion of shares shall be made on the same basis
and pursuant to the same rights and procedures as provided in the Certificate of
Designation as if such conversion were a conversion of such share(s) of Series C
Preferred Stock pursuant to the Certificate of Designation; provided, however,
that for purposes of determining the number of shares of Common Stock for which
any share of Series C Preferred Stock may be so converted, the holder shall be
entitled to make such conversion as if the Conversion Price (as defined in the
Certificate of Designation) initially were $3.00, subject to adjustment as
provided in the Certificate of Designation on the same terms therein provided as
if the Conversion Price initially were $3.00.

                  (b) The provisions of the Certificate of Designation are by
this reference incorporated herein as if set forth in full at this place for
purposes of setting forth the rights of holders of Series C Preferred Stock to
convert shares of Series C Preferred Stock in accordance with the rights
provided in this Agreement. Each reference in the Securities Purchase Agreement,
the Registration Rights Agreement or the Certificate of Designation to the
"Conversion Price" shall be deemed a reference to the price at which shares of
Series C Preferred Stock may be converted for Common Stock from time to time
pursuant to this Agreement.

                                       3
<PAGE>
                  (c) The shares of Common Stock issuable or issued upon
conversion of shares of Series C Preferred Stock pursuant to this Agreement
shall be "Registrable Securities" for purposes of the Registration Rights
Agreement.

                  3. COMPANY REPRESENTATIONS AND WARRANTIES.

         The Company represents and warrants to, and covenants and agrees with,
the Holders that:

                  (a) CONCERNING THE CONVERTIBLE SHARES. The shares of Common
Stock issuable upon the conversion of shares of Series C Preferred Stock from
time to time pursuant to this Agreement (the "Convertible Shares") have been
duly authorized and the Convertible Shares, when issued upon exercise of the
conversion rights provided herein, will be duly and validly issued, fully paid
and non-assessable, and will not subject the holder thereof to personal
liability by reason of being such holder.

                  (b) AMENDMENT AGREEMENT. This Agreement has been duly and
validly authorized by the Company and has been approved by the Board of
Directors of the Company and this Agreement has been duly executed and delivered
on behalf of the Company. This Agreement is the legal, valid and binding
obligation of the Company, enforceable in accordance with its terms, subject to
general principles of equity and to bankruptcy, insolvency, moratorium and other
similar laws affecting the enforcement of creditors' rights generally and limits
upon rights to indemnity.

                  (c) NON-CONTRAVENTION. The execution and delivery of this
Agreement by the Company and the issuance by the Company of the Convertible
Shares, as contemplated by this Agreement, and completion of the other
transactions contemplated in this Agreement, do not and will not conflict with
or result in a breach by the Company of any of the terms or provisions of, or
constitute a default under, the Certificate of Incorporation or By-Laws of the
Company, or any indenture, mortgage, deed of trust or other material agreement
or instrument to which the Company is a party or by which it or any of its
properties or assets are bound which would have a material adverse effect on the
Company, or any applicable law, rule or regulation or any applicable decree,
judgment or order of any court, United States federal or state regulatory body,
administrative agency or other governmental body having jurisdiction over the
Company or any of its properties or assets which would have a material adverse
effect on the Company.

                  (d) APPROVALS. No authorization, approval or consent of, or
notice to, or filing with, any court, governmental body, regulatory agency,
self-regulatory organization, or stock exchange or market or the stockholders of
the Company is required to be obtained by the Company for the issuance of
Convertible Shares upon exercise of the conversion rights provided in this
Agreement.

                  4. EFFECTIVENESS.

         This Agreement shall become effective on the date (the "Effective
Date") when this Agreement shall have been executed and delivered by the Company
and the Holders. From and after the Effective Date, all references in the
Securities Purchase Agreement, the Certificate of

                                       4
<PAGE>
Designations or the Registration Rights Agreement to the Securities Purchase
Agreement and the Registration Rights Agreement shall be deemed to be references
to the Securities Purchase Agreement and the Registration Rights Agreement as
amended hereby and by the First Amendment.

                  5. CONFIRMATION OF AGREEMENTS; ENTIRE AGREEMENT.

         Except as amended by this Agreement and the First Amendment, the
Securities Purchase Agreement, the Registration Rights Agreement and the
Certificate of Designation shall remain in effect in accordance with their
respective terms. This Agreement sets forth the entire agreement between or
among the parties with respect to the subject matter hereof.

                  6. MISCELLANEOUS.

                  (a) GOVERNING LAW. This Agreement shall be governed by and
interpreted in accordance with the laws of the State of New York, except that
Section 2 hereof shall be governed by and interpreted in accordance with the
laws of the State of Delaware.

                  (b) COUNTERPARTS. This Agreement may be executed in
counterparts and by the parties hereto on separate counterparts, all of which
together shall constitute one and the same instrument. A telephone line
facsimile copy of this Agreement bearing a signature on behalf of a party hereto
shall be legal and binding on such party.

                  (c) HEADINGS, ETC. The headings, captions and footers of this
Agreement are for convenience of reference and shall not form part of, or affect
the interpretation of, this Agreement.

                  (d) SEVERABILITY. If any provision of this Agreement shall be
invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the
remainder of this Agreement or the validity or enforceability of this Agreement
in any other jurisdiction.

                  (e) AMENDMENTS. No amendment, modification, waiver, discharge
or termination of any provision of this Agreement nor consent to any departure
by the Holders or the holders of record from time to time of the Series C
Preferred Stock or the Company therefrom shall in any event be effective unless
the same shall be in writing and signed by the party to be charged with
enforcement, which, in the case of the Holders shall mean Persons who at the
time are holders of record of at least 90 percent of the outstanding shares of
Series C Preferred Stock, and then shall be effective only in the specific
instance and for the purpose for which given. No course of dealing between the
parties hereto shall operate as an amendment of this Agreement.

                  (f) WAIVERS. Failure of any party to exercise any right or
remedy under this Agreement or otherwise, or delay by a party in exercising such
right or remedy, or any course of dealings between the parties, shall not
operate as a waiver thereof or an amendment hereof, nor shall any single or
partial exercise of any such right or power, or any abandonment or

                                       5
<PAGE>
discontinuance of steps to enforce such a right or power, preclude any other or
further exercise thereof or exercise of any other right or power.

                  (g) NOTICES. Any notices required or permitted to be given
under the terms of this Agreement shall be delivered in accordance with the
notice provisions of the Securities Purchase Agreement.

                  (h) SURVIVAL. The respective representations, warranties,
covenants, and agreements of the Holders and the Company contained in this
Agreement or made by or on behalf of them, respectively, pursuant to this
Agreement shall survive the Effective Date and the issuance of the Convertible
Shares and shall remain in full force and effect regardless of any investigation
made by or on behalf of them or any person controlling or advising any of them.

                  (i) FURTHER ASSURANCES. Each party to this Agreement will
perform any and all acts and execute any and all documents as may be necessary
and proper under the circumstances in order to accomplish the intents and
purposes of this Agreement and to carry out its provisions.

                  (j) CONSTRUCTION. The language used in this Agreement will be
deemed to be the language chosen by the parties to express their mutual intent,
and no rules of strict construction will be applied against any party.

                [Remainder of This Page Intentionally Left Blank]

                                       6
<PAGE>
                  IN WITNESS WHEREOF, this Agreement has been duly executed by
the Holders and the Company by their respective officers or other
representatives thereunto duly authorized as of the date first set forth above.

                                      LIFEPOINT, INC.

                                      By: Peter E. Jansen

                                             Name: Peter E. Jansen
                                             Title:   Vice President, Finance

                            SIGNATURES OF PURCHASERS

                                       7<PAGE>
                                                                    EXHIBIT 4(e)

         VOID AFTER 5:00 P.M., NEW YORK CITY
         TIME, ON JUNE __, 2006
         (UNLESS EXTENDED PURSUANT TO SECTION 2 HEREOF)

         THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
         NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
         "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED
         STATES OR ANY OTHER JURISDICTION. THE SECURITIES REPRESENTED HEREBY MAY
         NOT BE OFFERED OR SOLD IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
         STATEMENT FOR THE SECURITIES UNDER APPLICABLE SECURITIES LAWS UNLESS
         OFFERED, SOLD OR TRANSFERRED PURSUANT TO AN AVAILABLE EXEMPTION FROM
         THE REGISTRATION REQUIREMENTS OF THOSE LAWS.

                                            Right to Purchase ________ Shares of
                                         Common Stock, $.001 par value per share
Date:    ___________ ___, 2001

                                 LIFEPOINT, INC.
                             STOCK PURCHASE WARRANT

THIS CERTIFIES THAT, for value received, __________________, or its registered
assigns, is entitled to purchase from LIFEPOINT, INC., a corporation organized
under the laws of the State of Delaware (the "COMPANY"), at any time or from
time to time during the period specified in Section 2 hereof,
________________(________) fully paid and nonassessable shares of the Company's
common stock, $.001 par value per share (the "COMMON STOCK"), at an exercise
price per share (the "EXERCISE PRICE") equal to $3.00. Notwithstanding the
foregoing, the number of shares of the Common Stock purchasable hereunder (the
"WARRANT SHARES") and the Exercise Price are subject to adjustment as provided
in Section 4 hereof. The term "WARRANTS" means this Warrant and the other
warrants of the Company issued pursuant to that certain Securities Purchase
Agreement, dated as of June 20, 2001, by and among the Company and the other
signatories thereto (the "SECURITIES PURCHASE AGREEMENT"). This Warrant is
subject to the following terms, provisions and conditions:

         1. Manner of Exercise; Issuance of Certificates; Payment for Shares.
Subject to the provisions hereof, including, without limitation, the limitations
contained in Section 7 hereof, this Warrant may be exercised by the holder
hereof, in whole or in part, by the surrender of this Warrant, together with a
completed exercise agreement in the form attached hereto (the "EXERCISE
AGREEMENT"), to the Company by 4:30 p.m., Pacific time, on any business day at
the Company's principal executive offices (or such other office or agency of the
Company as it may

                                       1
<PAGE>
designate by notice to the holder hereof) and upon (i) payment to the Company in
cash, by certified or official bank check or by wire transfer for the account of
the Company, of the Exercise Price for the Warrant Shares specified in the
Exercise Agreement or (ii) if the holder is effectuating a Cashless Exercise (as
defined below) delivery to the Company of a written notice of an election to
effect a Cashless Exercise for the Warrant Shares specified in the Exercise
Agreement. This Warrant may be exercised at any time after the date hereof until
the end of the Exercise Period, by presentation and surrender of this Warrant to
the Company at its principal executive offices with a written notice of the
holder's intention to effect a cashless exercise, including a calculation of the
number of shares of the Common Stock to be issued upon such exercise in
accordance with the terms hereof (a "CASHLESS EXERCISE"). In the event of a
Cashless Exercise, in lieu of paying the Exercise Price in cash, the holder
shall surrender this Warrant for that number of shares of the Common Stock
determined by multiplying the number of Warrant Shares to which it would
otherwise be entitled by a fraction, the numerator of which shall be the
difference between the then current Market Price (as defined in Section 4(l)
below) of a share of the Common Stock on the date of exercise and the Exercise
Price, and the denominator of which shall be the then current Market Price per
share of the Common Stock. The Warrant Shares so purchased shall be deemed to be
issued to the holder hereof or such holder's designee, as the record owner of
such shares, as of the close of business on the date on which this Warrant shall
have been surrendered, the payment received by the Company and the completed
Exercise Agreement shall have been delivered or, if such date is not a business
date, on the next succeeding business date. The Warrant Shares so purchased,
representing the aggregate number of shares specified in the Exercise Agreement,
shall be delivered to the holder hereof within a reasonable time, not exceeding
five (5) business days, after this Warrant shall have been so exercised (the
"DELIVERY PERIOD"). If the Company's transfer agent is participating in the
Depository Trust Company ("DTC") Fast Automated Securities Transfer program, and
so long as the certificates therefor do not bear a legend and the holder is not
obligated to return such certificate for the placement of a legend thereon, the
Company shall cause its transfer agent to electronically transmit the Warrant
Shares so purchased to the holder by crediting the account of the holder or its
nominee with DTC through its Deposit Withdrawal Agent Commission system ("DTC
TRANSFER"). If the aforementioned conditions to a DTC Transfer are not
satisfied, the Company shall deliver to the holder physical certificates
representing the Warrant Shares so purchased. Further, the holder may instruct
the Company to deliver to the holder physical certificates representing the
Warrant Shares so purchased in lieu of delivering such shares by way of DTC
Transfer. Any certificates so delivered shall be in such denominations as may be
reasonably requested by the holder hereof, shall be registered in the name of
such holder or such other name as shall be designated by such holder and,
following the date on which the Warrant Shares have been registered under the
Securities Act pursuant to that certain Registration Rights Agreement, dated as
of the date hereof, by and among the Company and the other signatories thereto
(the "REGISTRATION RIGHTS AGREEMENT") or otherwise may be sold by the holder
pursuant to Rule 144(k) promulgated under the Securities Act (or a successor
rule), shall not bear any restrictive legend other then that related to delivery
of a prospectus. If this Warrant shall have been exercised only in part, then,
unless this Warrant has expired, the Company shall, at its expense, at the time
of delivery of such certificates, deliver to the holder a new Warrant
representing the number of shares with respect to which this Warrant shall not
then have been exercised.

                                       2
<PAGE>
         If, at any time, a holder of this Warrant submits this Warrant and an
Exercise Agreement, and the Company fails for any reason to deliver, on or prior
to the fifth (5th) business day following the expiration of the Delivery Period
for such exercise, the number of shares of the Common Stock to which the holder
is entitled upon such exercise (an "EXERCISE DEFAULT"), then the Company shall
pay to the holder payments ("EXERCISE DEFAULT PAYMENTS") for an Exercise Default
in the amount of (a) (N/365), multiplied by (b) the Market Price (as defined in
Section 4(l) hereof) on the date the Exercise Agreement giving rise to the
Exercise Default is transmitted in accordance with this Section 1 (the "EXERCISE
DEFAULT DATE"), multiplied by (c) the number of shares of the Common Stock the
Company failed to so deliver in such Exercise Default, multiplied by (d) .18,
where N = the number of days from the Exercise Default Date to the date that the
Company effects the full exercise of this Warrant which gave rise to the
Exercise Default. The accrued Exercise Default Payment for each calendar month
shall be paid in cash or shall be convertible into shares of the Common Stock,
at the holder's option, as follows:

                  a. In the event the holder elects to take such payment in
cash, cash payment shall be made to holder by the fifth (5th) day of the month
following the month in which it has accrued; and

                  b. In the event the holder elects to take such payment in
shares of the Common Stock, the holder may convert such payment amount into
shares of the Common Stock (in accordance with the terms contained in Article IV
of the Certificate of Designation of Rights and Preferences (the "CERTIFICATE OF
DESIGNATION") governing the Company's Series C Convertible Preferred Stock (the
"SERIES C PREFERRED STOCK") as if such payment amount was the Stated Value (as
defined in the Certificate of Designation) of shares of Series C Preferred Stock
at the lower of the Exercise Price or the Market Price (as defined in Section
4(l)) (as in effect at the time of conversion) at any time after the fifth (5th)
day of the month following the month in which it has accrued.

         Nothing herein shall limit the holder's right to pursue actual damages
for the Company's failure to maintain a sufficient number of authorized shares
of the Common Stock as required pursuant to the terms of Section 3(b) hereof or
to otherwise issue shares of the Common Stock upon exercise of this Warrant in
accordance with the terms hereof, and the holder shall have the right to pursue
all remedies available at law or in equity (including a decree of specific
performance and/or injunctive relief).

         2. This Warrant is immediately exercisable, at any time or from time to
time on or after the date of initial issuance of this Warrant (the "ISSUE DATE")
and before 4:30 p.m., Pacific time, on that date which is five (5) years after
the Issue Date (the "EXERCISE PERIOD"). The Exercise Period shall automatically
be extended (i) by one (1) day for each day on which the Company does not have a
number of shares of the Common Stock reserved for issuance upon exercise hereof
at least equal to the number of shares of the Common Stock issuable upon
exercise hereof and (ii) for so long as (A) a Redemption Event (as defined in
the Certificate of Designation) shall have occurred and be continuing or (B) any
event shall have occurred and be continuing which, with the passage of time or
the giving of notice and the failure to cure, would result in a Redemption
Event.

                                       3
<PAGE>
         3. Certain Agreements of the Company. The Company hereby covenants and
agrees as follows:

                  a. Shares to be Fully Paid. All Warrant Shares will, upon
issuance in accordance with the terms of this Warrant, be validly issued, fully
paid, and nonassessable and free from all taxes, liens, claims and encumbrances
arising from the acts or omissions of the Company.

                  b. Reservation of Shares. During the Exercise Period, the
Company shall at all times have authorized, and reserved for the purpose of
issuance upon exercise of this Warrant, a sufficient number of shares of the
Common Stock to provide for the exercise in full of this Warrant (without giving
effect to the limitations on exercise set forth in Section 7(g) hereof).

                  c. Listing. The Company shall promptly secure the listing of
the shares of the Common Stock issuable upon exercise of this Warrant upon each
national securities exchange or automated quotation system, if any, upon which
shares of the Common Stock are then listed or become listed (subject to official
notice of issuance upon exercise of this Warrant) and shall maintain, so long as
any other shares of the Common Stock shall be so listed, such listing of all
shares of the Common Stock from time to time issuable upon the exercise of this
Warrant; and the Company shall so list on each national securities exchange or
automated quotation system, as the case may be, and shall maintain such listing
of, any other shares of capital stock of the Company issuable upon the exercise
of this Warrant if and so long as any shares of the same class shall be listed
on such national securities exchange or automated quotation system.

                  d. Certain Actions Prohibited. The Company will not, by
amendment of its Certificate of Incorporation or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities, or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed by it hereunder,
but will at all times in good faith assist in the carrying out of all the
provisions of this Warrant and in the taking of all such action as may
reasonably be requested by the holder of this Warrant in order to protect the
economic benefit inuring to the holder hereof and the exercise privilege of the
holder of this Warrant against dilution or other impairment, consistent with the
tenor and purpose of this Warrant. Without limiting the generality of the
foregoing, the Company (i) will not increase the par value of any shares of the
Common Stock receivable upon the exercise of this Warrant above the Exercise
Price then in effect, and (ii) will take all such actions as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid
and nonassessable shares of the Common Stock upon the exercise of this Warrant.

                  e. Successors and Assigns. This Warrant will be binding upon
any entity succeeding to the Company by merger, consolidation, or acquisition of
all or substantially all of the Company's assets.

                  f. Blue Sky Laws. In the event the issuance of the Warrant
Shares is not within an applicable exemption thereto, the Company shall, on or
before the date of issuance of any Warrant Shares, take such actions as the
Company shall reasonably determine are necessary

                                       4
<PAGE>
to qualify the Warrant Shares for, or obtain exemption for the Warrant Shares
for, sale to the holder of this Warrant upon the exercise hereof under
applicable securities or "blue sky" laws of the states of the United States, and
shall provide evidence of any such action so taken to the holder of this Warrant
prior to such date; provided, however, that the Company shall not be required to
qualify as a foreign corporation or file a general consent to service of process
in any such jurisdiction.

         4. Antidilution Provisions. During the Exercise Period, the Exercise
Price and the number of Warrant Shares issuable hereunder and for which this
Warrant is then exercisable pursuant to Section 2 hereof shall be subject to
adjustment from time to time as provided in this Section 4. In the event that
any adjustment of the Exercise Price as required herein results in a fraction of
a cent, such Exercise Price shall be rounded up or down to the nearest cent.

                  a. Adjustment of Exercise Price. Except as otherwise provided
in Sections 4(c) and 4(e) hereof, if and whenever on or prior to June 19, 2004
the Company issues or sells, or in accordance with Section 4(b) hereof is deemed
to have issued or sold, any shares of the Common Stock for no consideration or
for a consideration per share less than the Dilutive Price (as defined in this
subparagraph) on the date of issuance or deemed issuance of such shares of the
Common Stock (a "DILUTIVE ISSUANCE"), then effective immediately upon the
Dilutive Issuance, the Exercise Price will be adjusted to equal the per share
amount at which such shares of the Common Stock were issued or sold (or deemed
to have been issued or sold pursuant to Section 4(b)). For purposes of this
Section 4, "Dilutive Price" means at any time the Conversion Price then in
effect.

                  b. Effect on Exercise Price of Certain Events. For purposes of
determining the adjusted Exercise Price under Section 4(a) hereof, the following
will be applicable:

                           i Issuance of Rights or Options. If the Company in
any manner issues or grants any warrants, rights or options, whether or not
immediately exercisable, to subscribe for or to purchase shares of the Common
Stock or other securities exercisable, convertible into or exchangeable for
shares of the Common Stock ("CONVERTIBLE SECURITIES") (such warrants, rights and
options to purchase shares of the Common Stock or Convertible Securities are
hereinafter referred to as "OPTIONS") and the price per share for which a share
of the Common Stock is issuable upon the exercise of such Options is less than
the Dilutive Price in effect on the date of issuance of such Options ("BELOW
MARKET OPTIONS"), then the shares of the Common Stock issuable upon the exercise
of all such Below Market Options (assuming full exercise, conversion or exchange
of Convertible Securities, if applicable) will, as of the date of the issuance
or grant of such Below Market Options, be deemed to be outstanding and to have
been issued and sold by the Company for such price per share. For purposes of
the preceding sentence, the "price per share for which a share of the Common
Stock is issuable upon the exercise of such Below Market Options" is determined
by dividing (i) the total amount, if any, received or receivable by the Company
as consideration for the issuance or granting of all such Below Market Options,
plus the minimum aggregate amount of additional consideration, if any, payable
to the Company upon the exercise of all such Below Market Options, plus, in the
case of Convertible Securities issuable upon the exercise of such Below Market
Options, the minimum aggregate amount of additional consideration payable upon
the exercise, conversion or exchange thereof at the time such Convertible
Securities first become exercisable, convertible or

                                       5
<PAGE>
exchangeable, by (ii) the maximum total number of shares of the Common Stock
issuable upon the exercise of all such Below Market Options (assuming full
conversion of Convertible Securities, if applicable). No further adjustment to
the Exercise Price will be made upon the actual issuance of such shares of the
Common Stock upon the exercise of such Below Market Options or upon the
exercise, conversion or exchange of Convertible Securities issuable upon
exercise of such Below Market Options.

                           ii Issuance of Convertible Securities.

                                    A If the Company in any manner issues or
sells any Convertible Securities, whether or not immediately convertible (other
than where the same are issuable upon the exercise of Options) and the price per
share for which a share of the Common Stock is issuable upon such exercise,
conversion or exchange (as determined pursuant to Section 4(b)(ii)(B) if
applicable) is less than the Dilutive Price in effect on the date of issuance of
such Convertible Securities, then the shares of the Common Stock issuable upon
the exercise, conversion or exchange of all such Convertible Securities will, as
of the date of the issuance of such Convertible Securities, be deemed to be
outstanding and to have been issued and sold by the Company for such price per
share. For the purposes of the preceding sentence, the "price per share for
which a share of the Common Stock is issuable upon such exercise, conversion or
exchange" is determined by dividing (i) the total amount, if any, received or
receivable by the Company as consideration for the issuance or sale of all such
Convertible Securities, plus the minimum aggregate amount of additional
consideration, if any, payable to the Company upon the exercise, conversion or
exchange thereof at the time such Convertible Securities first become
exercisable, convertible or exchangeable, by (ii) the maximum total number of
shares of the Common Stock issuable upon the exercise, conversion or exchange of
all such Convertible Securities. No further adjustment to the Exercise Price
will be made upon the actual issuance of such shares of the Common Stock upon
exercise, conversion or exchange of such Convertible Securities.

                                    B If the Company in any manner issues or
sells any Convertible Securities with a fluctuating conversion or exercise price
or exchange ratio (a "VARIABLE RATE CONVERTIBLE SECURITY"), then the "price per
share for which a share of the Common Stock is issuable upon such exercise,
conversion or exchange" for purposes of the calculation contemplated by Section
4(b)(ii)(A) shall be deemed to be the lowest price per share which would be
applicable (assuming all holding period and other conditions to any discounts
contained in such Convertible Security have been satisfied) if the Dilutive
Price on the date of issuance of such Convertible Security was 75% of the
Dilutive Price on such date (the "ASSUMED VARIABLE MARKET PRICE"). Further, if
the Dilutive Price at any time or times thereafter is less than or equal to the
Assumed Variable Market Price last used for making any adjustment under this
Section 4 with respect to any Variable Rate Convertible Security, the Exercise
Price in effect at such time shall be readjusted to equal the Exercise Price
which would have resulted if the Assumed Variable Market Price at the time of
issuance of the Variable Rate Convertible Security had been 75% of the Dilutive
Price existing at the time of the adjustment required by this sentence.

                           iii Change in Option Price or Conversion Rate. If
there is a reduction at any time in (i) the amount of additional consideration
payable to the Company upon the

                                       6
<PAGE>
exercise of any Options; (ii) the amount of additional consideration, if any,
payable to the Company upon the exercise, conversion or exchange of any
Convertible Securities; or (iii) the rate at which any Convertible Securities
are convertible into or exchangeable for shares of the Common Stock, the
Exercise Price in effect at the time of such change will be readjusted to the
Exercise Price which would have been in effect at such time had such Options or
Convertible Securities still outstanding provided for such changed additional
consideration or changed conversion rate, as the case may be, at the time
initially granted, issued or sold.

                           iv Treatment of Expired Options and Unexercised
Convertible Securities. If, in any case, the total number of shares of the
Common Stock issuable upon exercise of any Option or upon exercise, conversion
or exchange of any Convertible Securities is not, in fact, issued and the rights
to exercise such Option or to exercise, convert or exchange such Convertible
Securities shall have expired or terminated, the Exercise Price then in effect
will be readjusted to the Exercise Price which would have been in effect at the
time of such expiration or termination had such Option or Convertible
Securities, to the extent outstanding immediately prior to such expiration or
termination (other than in respect of the actual number of shares of the Common
Stock issued upon exercise or conversion thereof), never been issued.

                           v Calculation of Consideration Received. If any
shares of the Common Stock, Options or Convertible Securities are issued,
granted or sold for cash, the consideration received therefor for purposes of
this Warrant will be the amount received by the Company therefor, before
deduction of reasonable commissions, underwriting discounts or allowances or
other reasonable expenses paid or incurred by the Company in connection with
such issuance, grant or sale. In case any shares of the Common Stock, Options or
Convertible Securities are issued or sold for a consideration part or all of
which shall be other than cash, the amount of the consideration other than cash
received by the Company will be the fair market value of such consideration,
except where such consideration consists of securities, in which case the amount
of consideration received by the Company will be the Market Price thereof as of
the date of receipt. In case any shares of the Common Stock, Options or
Convertible Securities are issued in connection with any merger or consolidation
in which the Company is the surviving corporation, the amount of consideration
therefor will be deemed to be the fair market value of such portion of the net
assets and business of the non-surviving corporation as is attributable to such
shares of the Common Stock, Options or Convertible Securities, as the case may
be. The fair market value of any consideration other than cash or securities
will be determined in good faith by an investment banker or other appropriate
expert of national reputation selected by the Company and reasonably acceptable
to the holder hereof, with the costs of such determination to be borne by the
Company. In case any shares of the Common Stock, Options or Convertible
Securities are issued in connection with the issuance of debt securities the
amount of consideration therefor shall be the cash received by the Company and
the value of the securities issued by the Company shall be the fair market value
of all securities and instruments issued in such transaction, with fair market
value being determined by agreement between the holder hereof and the Company or
if no such agreement is reached pursuant to the immediately preceding sentence.
For all Options and Warrants the fair market value thereof shall be determined
in accordance with the black shoals methodology.

                           vi Exceptions to Adjustment of Exercise Price. No
adjustment to the Exercise Price will be made (i) upon the exercise of any
warrants, options or convertible

                                       7
<PAGE>
securities issued and outstanding on the Issuance Date that are set forth on
Schedule 3(d) of the Securities Purchase Agreement in accordance with the terms
of such securities as of such date or (ii) upon the grant or exercise of any
stock, options or warrants which may hereafter be granted or exercised, whether
under any employee benefit plan of the Company now existing or to be implemented
in the future or otherwise granted to or exercised by an employee, so long as
the issuance of such stock, options or warrant is approved by a majority of the
non-employee members of the Board of Directors of the Company, if any, or a
majority of the members of a committee of non-employee directors established for
such purpose; (iii) the issuance of securities in connection with strategic
transactions involving the Company and other entities, including joint ventures,
manufacturing, marketing or distribution arrangements (but excluding any sale of
substantially all of the Company's assets or any merger or consolidation of the
Company into or with another entity in which the holders of the capital stock of
the Company immediately prior to such merger or consolidation do not hold at
least fifty percent (50%) in voting power of the surviving corporation); and
(iv) the issuance of stock, warrants or other securities or rights to persons or
entities in connection with lease lines, bank financing or similar transactions,
provided that such issuances are primarily for purposes other than equity
financing.

                  c. Subdivision or Combination of the Common Stock. If the
Company, at any time during the Exercise Period, subdivides (by any stock split,
stock dividend, recapitalization, reorganization, reclassification or otherwise)
its shares of the Common Stock into a greater number of shares, then, after the
date of record for effecting such subdivision, the Exercise Price in effect
immediately prior to such subdivision will be proportionately reduced. If the
Company, at any time during the Exercise Period, combines (by reverse stock
split, recapitalization, reorganization, reclassification or otherwise) its
shares of the Common Stock into a smaller number of shares, then, after the date
of record for effecting such combination, the Exercise Price in effect
immediately prior to such combination will be proportionately increased.

                  d. Adjustment in Number of Shares. Upon each adjustment of the
Exercise Price pursuant to the provisions of this Section 4, the number of
shares of the Common Stock issuable upon exercise of this Warrant and for which
this Warrant is or may become exercisable shall be adjusted by multiplying a
number equal to the Exercise Price in effect immediately prior to such
adjustment by the number of shares of the Common Stock issuable or for which
this Warrant is or may become exercisable (as applicable) upon exercise of this
Warrant immediately prior to such adjustment and dividing the product so
obtained by the adjusted Exercise Price.

                  e. Consolidation, Merger or Sale. In case of any consolidation
of the Company with, or merger of the Company into, any other corporation, or in
case of any sale or conveyance of all or substantially all of the assets of the
Company other than in connection with a plan of complete liquidation of the
Company at any time during the Exercise Period, then as a condition of such
consolidation, merger or sale or conveyance, adequate provision will be made
whereby the holder of this Warrant will have the right to acquire and receive
upon exercise of this Warrant in lieu of the shares of the Common Stock
immediately theretofore acquirable upon the exercise of this Warrant, such
shares of stock, securities, cash or assets as may be issued or payable with
respect to or in exchange for the number of shares of the Common Stock
immediately theretofore acquirable and receivable upon exercise of this Warrant
had such consolidation, merger or sale or conveyance not taken place. In any
such case, the Company will make appropriate provision to insure that the
provisions of this Section 4 hereof will thereafter

                                       8
<PAGE>
be applicable as nearly as may be in relation to any shares of stock or
securities thereafter deliverable upon the exercise of this Warrant. The Company
will not effect any consolidation, merger or sale or conveyance unless prior to
the consummation thereof, the successor corporation (if other than the Company)
assumes by written instrument the obligations under this Warrant and the
obligations to deliver to the holder of this Warrant such shares of stock,
securities or assets as, in accordance with the foregoing provisions, the holder
may be entitled to acquire. Notwithstanding the foregoing, in the event of any
such sale or conveyance, the holder of this Warrant shall, at its option, have
the right to receive cash consideration equal to the fair market value of this
Warrant as determined in accordance with customary valuation methodology used in
the investment banking industry if any such merger, consolidation, sale or
conveyance either involves (x) the receipt of cash consideration by the equity
holders of the Company's capital stock or (y) (i) the sale of the securities
issuable upon exercise of all Warrants immediately following such event is not
either registered with the Securities and Exchange Commission or exempt from all
applicable federal and state registration requirements and such securities are
not listed for trading on the New York Stock Exchange, the American Stock
Exchange, the Nasdaq National Market or the Nasdaq SmallCap Market, and (ii) the
average weekly reported volume of trading of such securities on the principal
exchange or market on which such securities are traded for the twelve (12)
calendar weeks immediately preceding the public announcement of such
transaction, is less than the product of the aggregate number of shares issuable
upon exercise of all Warrants following such event and ten (10).

                  f. Distribution of Assets. In case the Company shall declare
or make any distribution of its assets (or rights to acquire its assets) to
holders of the Common Stock as a partial liquidating dividend, stock repurchase
by way of return of capital or otherwise (including any dividend or distribution
to the Company's stockholders of cash or shares (or rights to acquire shares) of
capital stock of a subsidiary) (a "DISTRIBUTION"), at any time during the
Exercise Period, then the holder of this Warrant shall be entitled upon exercise
of this Warrant for the purchase of any or all of the shares of the Common Stock
subject hereto, to receive the amount of such assets (or rights) which would
have been payable to the holder had such holder been the holder of such shares
of the Common Stock on the record date for the determination of stockholders
entitled to such Distribution.

                  g. Notice of Adjustment. Upon the occurrence of any event
which requires any adjustment of the Exercise Price, then, and in each such
case, the Company shall give notice thereof to the holder of this Warrant, which
notice shall state the Exercise Price resulting from such adjustment and the
increase or decrease in the number of Warrant Shares purchasable at such price
upon exercise, setting forth in reasonable detail the method of calculation and
the facts upon which such calculation is based. Such calculation shall be
certified by the chief financial or accounting officer of the Company.

                  h. Minimum Adjustment of Exercise Price. No adjustment of the
Exercise Price shall be made in an amount of less than 1% of the Exercise Price
in effect at the time such adjustment is otherwise required to be made, but any
such lesser adjustment shall be carried forward and shall be made at the time
and together with the next subsequent adjustment which, together with any
adjustments so carried forward, shall amount to not less than 1% of such
Exercise Price.

                                       9
<PAGE>
                  i. No Fractional Shares. No fractional shares of the Common
Stock are to be issued upon the exercise of this Warrant, but the Company shall
pay a cash adjustment in respect of any fractional share which would otherwise
be issuable in an amount equal to the same fraction of the Market Price of a
share of the Common Stock on the date of such exercise.

                  j. Other Notices. In case at any time:

                           i the Company shall declare any dividend upon the
Common Stock payable in shares of stock of any class or make any other
distribution (other than dividends or distributions payable in cash out of
retained earnings consistent with the Company's past practices with respect to
declaring dividends and making distributions) to the holders of the Common
Stock;

                           ii the Company shall offer for subscription pro rata
to the holders of the Common Stock any additional shares of stock of any class
or other rights;

                           iii there shall be any capital reorganization of the
Company, or reclassification of the Common Stock, or consolidation or merger of
the Company with or into, or sale of all or substantially all of its assets to,
another corporation or entity; or

                           iv there shall be a voluntary or involuntary
dissolution, liquidation or winding-up of the Company;

then, in each such case, the Company shall give to the holder of this Warrant
(a) notice of the date on which the books of the Company shall close or a record
shall be taken for determining the holders of the Common Stock entitled to
receive any such dividend, distribution, or subscription rights or for
determining the holders of the Common Stock entitled to vote in respect of any
such reorganization, reclassification, consolidation, merger, sale, dissolution,
liquidation or winding-up and (b) in the case of any such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or
winding-up, notice of the date (or, if not then known, a reasonable estimate
thereof by the Company) when the same shall take place. Such notice shall also
specify the date on which the holders of the Common Stock shall be entitled to
receive such dividend, distribution, or subscription rights or to exchange their
shares of the Common Stock for stock or other securities or property deliverable
upon such reorganization, reclassification, consolidation, merger, sale,
dissolution, liquidation, or winding-up, as the case may be. Such notice shall
be given at least twenty (20) days prior to the record date or the date on which
the Company's books are closed in respect thereto, but in no circumstance prior
to the information being publicly disclosed. Failure to give any such notice or
any defect therein shall not affect the validity of the proceedings referred to
in clauses (i), (ii), (iii) and (iv) above. Notwithstanding the foregoing, the
Company shall publicly disclose the substance of any notice delivered hereunder
prior to delivery of such notice to the holder of this Warrant.

                  k. Certain Events. If, at any time during the Exercise Period,
any event occurs of the type contemplated by the adjustment provisions of this
Section 4 but not expressly

                                       10
<PAGE>
provided for by such provisions, the Company will give notice of such event as
provided in Section 4(g) hereof, and the Company's Board of Directors will make
an appropriate adjustment in the Exercise Price and the number of shares of the
Common Stock acquirable upon exercise of this Warrant so that the rights of the
holder shall be neither enhanced nor diminished by such event.

                  l. Certain Definitions.

                           i "MARKET PRICE," as of any date, (i) means the
average of the Closing Sales Prices for the shares of the Common Stock as
reported on The American Stock Exchange (the "AMEX") by Bloomberg Financial
Markets ("BLOOMBERG") for the twenty (20) consecutive trading days immediately
preceding such date, or (ii) if AMEX is not the principal trading market for the
shares of the Common Stock, the average of the closing sales price or, if not so
reported, the average of the closing bid and asked prices as reported by
Bloomberg on the principal trading market for the Common Stock during the same
period, or, if there is no sale price for such period, the average of the last
reported bid and asked prices as reported by Bloomberg for such period, or (iii)
if market value cannot be calculated as of such date on any of the foregoing
bases, the Market Price shall be the average fair market value as reasonably
determined by an investment banking firm selected by the Company and reasonably
acceptable to the holder, with the costs of the determination to be borne by the
Company. The manner of determining the Market Price of the Common Stock set
forth in the foregoing definition shall apply with respect to any other security
in respect of which a determination as to market value must be made hereunder.

                           ii "COMMON STOCK," for purposes of this Section 4,
includes the Common Stock and any additional class of stock of the Company
having no preference as to dividends or distributions on liquidation, provided
that the shares purchasable pursuant to this Warrant shall include only shares
of the Common Stock in respect of which this Warrant is exercisable, or shares
resulting from any subdivision or combination of the Common Stock, or in the
case of any reorganization, reclassification, consolidation, merger, or sale of
the character referred to in Section 4(e) hereof, the stock or other securities
or property provided for in such Section.

                           iii "CLOSING SALES PRICE," as of any date, (i) means
the closing sales price for the shares of the Common Stock as reported on the
AMEX by Bloomberg, or (ii) if the AMEX is not the principal trading market for
the shares of the Common Stock, the average of the closing sales prices, or, if
not so reported, the average of the closing bid and asked prices as reported by
Bloomberg on the principal trading market for the Common Stock during the same
period, or, if there is no sale price for such period, the last reported bid
price as reported by Bloomberg for such period, or (iii) if the Closing Sales
Price cannot be calculated as of such date on any of the foregoing bases, the
Closing Sales Price on any such date shall be the average fair market value as
reasonably determined by an investment banking firm selected by the Company and
reasonably acceptable to the holder, with the costs of the determination to be
borne by the Company. The manner of determining the Closing Sales Price of the
Common Stock set forth in the foregoing definition shall apply with respect to
any other security in respect of which a determination as to market value must
be made hereunder.

                                       11
<PAGE>
         5. Issue Tax. The issuance of certificates for Warrant Shares upon the
exercise of this Warrant shall be made without charge to the holder of this
Warrant or such shares for any issuance tax or other costs in respect thereof,
provided that the Company shall not be required to pay any tax which may be
payable in respect of any transfer involved in the issuance and delivery of any
certificate in a name other than the holder of this Warrant.

         6. No Rights or Liabilities as a Stockholder. This Warrant shall not
entitle the holder hereof to any voting rights or other rights as a stockholder
of the Company. No provision of this Warrant, in the absence of affirmative
action by the holder hereof to purchase Warrant Shares, and no mere enumeration
herein of the rights or privileges of the holder hereof, shall give rise to any
liability of such holder for the Exercise Price or as a stockholder of the
Company, whether such liability is asserted by the Company or by creditors of
the Company.

         7. Transfer, Exchange, Redemption and Replacement of Warrant.

                  a. Restriction on Transfer. This Warrant and the rights
granted to the holder hereof are transferable, in whole or in part, upon
surrender of this Warrant, together with a properly executed assignment in the
form attached hereto, at the office or agency of the Company referred to in
Section 7(e) below, provided, however, that any transfer or assignment shall be
subject to the conditions set forth in Sections 7(f) and (g) hereof and to the
provisions of Sections 2(f) and 2(g) of the Securities Purchase Agreement. Until
due presentment for registration of transfer on the books of the Company, the
Company may treat the registered holder hereof as the owner and holder hereof
for all purposes, and the Company shall not be affected by any notice to the
contrary. Notwithstanding anything to the contrary contained herein, the
registration rights described in Section 8 hereof are assignable only in
accordance with the provisions of the Registration Rights Agreement.

                  b. Warrant Exchangeable for Different Denominations. This
Warrant is exchangeable, upon the surrender hereof by the holder hereof at the
office or agency of the Company referred to in Section 7(e) below, for new
Warrants of like tenor of different denominations representing in the aggregate
the right to purchase the number of shares of the Common Stock which may be
purchased hereunder, each of such new Warrants to represent the right to
purchase such number of shares as shall be designated by the holder hereof at
the time of such surrender.

                  c. Replacement of Warrant. Upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction, or mutilation of
this Warrant and, in the case of any such loss, theft, or destruction, upon
delivery of an indemnity agreement reasonably satisfactory in form and amount to
the Company, or, in the case of any such mutilation, upon surrender and
cancellation of this Warrant, the Company, at its expense, will execute and
deliver, in lieu thereof, a new Warrant of like tenor.

                  d. Cancellation; Payment of Expenses. Upon the surrender of
this Warrant in connection with any transfer, exchange, or replacement as
provided in this Section 7, this Warrant shall be promptly canceled by the
Company. The Company shall pay all taxes (other than securities transfer taxes)
and all other expenses (other than legal expenses, if any, incurred

                                       12
<PAGE>
by the holder or transferees) and charges payable in connection with the
preparation, execution, and delivery of Warrants pursuant to this Section 7. The
Company shall indemnify and reimburse the holder of this Warrant for all losses
and damages arising as a result of or related to any breach of the terms of this
Warrant, including costs and expenses (including reasonable legal fees) incurred
by such holder in connection with the enforcement of its rights hereunder.

                  e. Warrant Register. The Company shall maintain, at its
principal executive offices (or such other office or agency of the Company as it
may designate by notice to the holder hereof), a register for this Warrant, in
which the Company shall record the name and address of the person in whose name
this Warrant has been issued, as well as the name and address of each transferee
and each prior owner of this Warrant.

                  f. Exercise or Transfer Without Registration. If, at the time
of the surrender of this Warrant in connection with any exercise, transfer, or
exchange of this Warrant, this Warrant (or, in the case of any exercise, the
Warrant Shares issuable hereunder), shall not be registered under the Securities
Act and under applicable state securities or blue sky laws, the Company may
require, as a condition of allowing such exercise, transfer, or exchange, (i)
delivery to the Company of a written opinion of legal counsel (which opinion
shall be in form, substance and scope customary for opinions of counsel in
comparable transactions) to the effect that such exercise, transfer, or exchange
may be made without registration under the Securities Act and under applicable
state securities or blue sky laws (the cost of which shall be borne by the
Company if the Company's counsel renders such an opinion and up to $250 of such
cost shall be borne by the Company if the holder's counsel is requested to
render such opinion), (ii) that the holder or transferee execute and deliver to
the Company an investment letter in form and substance reasonably acceptable to
the Company, confirming such matters as shall be required by applicable
securities laws, and (iii) that the transferee be an "accredited investor" as
defined in Rule 501(a) promulgated under the Securities Act; provided that no
such opinion, letter, or status as an "accredited investor" shall be required in
connection with a transfer pursuant to Rule 144 under the Securities Act.

                  g. Additional Restrictions on Exercise or Transfer. Unless the
holder of this Warrant delivers a waiver in accordance with the second to last
sentence of this subsection (g), this Warrant shall not be exercisable by a
holder hereof to the extent (but only to the extent) that the sum of (a) the
number of shares of the Common Stock beneficially owned by such holder and its
affiliates, and (b) the number of shares of the Common Stock issuable upon
exercise of the Warrant (or portion thereof) with respect to which the
determination described herein is being made would result in beneficial
ownership by such holder and its affiliates of more than 4.99% of the
outstanding shares of the Common Stock. For purposes of this subsection (g),
beneficial ownership shall be determined in accordance with Section 13(d) of the
Securities Exchange Act of 1934, as amended, and Regulation 13D-G thereunder.
Notwithstanding the foregoing, a holder may, by providing written notice to the
Company, (x) adjust the restriction set forth in this subsection (g) so that the
limitations on beneficial ownership of 4.99% of the outstanding shares of the
Common Stock referred to above shall not be applicable to such holder, which
adjustment shall not take effect until the 61st day after the date of such
notice, and (y) irrevocably waive the right to deliver a waiver in accordance
with this sentence; provided, however, that, if such adjustment would result in
beneficial ownership greater than 9.99% of the outstanding shares of

                                       13
<PAGE>
the Common Stock, by such holder and its affiliates, then such adjustment shall
not take effect until the 75th day after the date of such notice.
Notwithstanding the foregoing, this Section 7(g) shall not apply to any holder
who prior to the date hereof owns more than 4.99% of the Company's outstanding
Common Stock.

         8. Registration Rights. The initial holder of this Warrant (and certain
assignees thereof) is entitled to the benefit of such registration rights in
respect of the Warrant Shares as are set forth in the Registration Rights
Agreement, including the right to assign such rights to certain assignees, as
set forth therein.

         9. Notices. Any notices required or permitted to be given under the
terms of this Warrant shall be sent by certified or registered mail (return
receipt requested) or delivered personally or by courier or by confirmed
telecopy, and shall be effective upon receipt or refusal of receipt, if
delivered personally or by courier, or by confirmed telecopy, in each case
addressed to a party. The addresses for such communications shall be:

         10. If to the Company:

                            LifePoint, Inc.
                            1205 South Dupont Street
                            Ontario, California 91761
                            Telephone: (909) 418-3000
                            Telecopy: (909) 418-3003
                            Attn:  Linda H. Masterson, Chief Executive Officer

                            with a copy to:
                            Wachtel & Masyr, LLP
                            110 East 59th Street, 27th Floor
                            New York, New York 10022
                            Telephone:  (212) 909-9602
                            Telecopy:   (212) 909-9455
                            Attn:  Robert W. Berend, Esq.

If to the holder, at such address as such holder shall have provided in writing
to the Company, or at such other address as such holder furnishes by notice
given in accordance with this Section 10.

         11. Governing Law; Jurisdiction. This Warrant shall be governed by and
construed in accordance with the laws of the State of Delaware applicable to
contracts made and to be performed in the State of Delaware, without regard to
principles of choice of law or conflicts of law that would defer to the
substantive law of another jurisdiction. The Company irrevocably consents to the
jurisdiction of the United States federal courts and state courts located in the
County and State of New York in any suit or proceeding based on or arising under
this Warrant and irrevocably agrees that all claims in respect of such suit or
proceeding shall be determined exclusively in such courts. The Company
irrevocably waives any objection to the laying of venue and the defense of an
inconvenient forum to the maintenance of such suit or proceeding. The Company
further agrees that service of process upon the Company mailed by certified or
registered mail shall be deemed in every respect effective service of process
upon the Company

                                       14
<PAGE>
in any such suit or proceeding; provided that nothing herein shall prevent the
Company from seeking to remove from the state court to the federal court or vice
versa. Nothing herein shall affect the holder's right to serve process in any
other manner permitted by law. The Company agrees that a final non-appealable
judgment in any such suit or proceeding shall be conclusive and may be enforced
in other jurisdictions by suit on such judgment or in any other lawful manner.

         12. Miscellaneous.

                  a. Amendments. This Warrant and any provision hereof may only
be amended by an instrument in writing signed by the Company and the holder
hereof.

                  b. Descriptive Headings. The descriptive headings of the
several Sections of this Warrant are inserted for purposes of reference only,
and shall not affect the meaning or construction of any of the provisions
hereof.

                  c. Business Day. For purposes of this Warrant, the term
"business day" means any day, other than a Saturday or Sunday or a day on which
banking institutions in the State of New York are authorized or obligated by
law, regulation or executive order to close.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       15
<PAGE>
         IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by
its duly authorized officer.

                                        LIFEPOINT, INC.

                                         By:
                                            ------------------------------------
                                            Name:
                                                 -------------------------------
                                            Title:
                                                  ------------------------------

                                       16
<PAGE>
                           FORM OF EXERCISE AGREEMENT
         (TO BE EXECUTED BY THE HOLDER IN ORDER TO EXERCISE THE WARRANT)

To:  LifePoint, Inc.
     1205 South Dupont Street
     Ontario, California  91761
     Telecopy: (909) 418-3003
     Attn: Linda H. Masterson, Chief Executive Officer

         The undersigned hereby irrevocably exercises the right to purchase
_____________ shares of the Common Stock of LifePoint, Inc., a corporation
organized under the laws of the State of Delaware (the "COMPANY"), evidenced by
the attached Warrant, in accordance with the conditions and provisions of said
Warrant. The undersigned shall submit as payment for such purchase, at the
option of the holder, either (i) an amount equal to the product of the Exercise
Price multiplied by the number of shares being purchased hereby, or (ii)
forfeiture of a number of shares of the Common Stock which would have been
issuable under the Warrant equal to the aggregate Exercise Price payable for
such exercise divided by the Market Price. All capitalized terms used herein and
not otherwise defined shall have the meanings ascribed to such terms in the
Warrant.

The undersigned agrees not to offer, sell, transfer or otherwise dispose of any
Common Stock obtained on exercise of the Warrant, except under circumstances
that will not result in a violation of the Securities Act of 1933, as amended,
or any state securities laws.

[ ]      The undersigned requests that the Company cause its transfer agent to
         electronically transmit the shares of the Common Stock issuable
         pursuant to this Exercise Agreement to the account of the undersigned
         or its nominee (which is _________________) with DTC through its
         Deposit Withdrawal Agent Commission System ("DTC TRANSFER").

[ ]      In lieu of receiving the shares of the Common Stock issuable pursuant
         to this Exercise Agreement by way of DTC Transfer, the undersigned
         hereby requests that the Company cause its transfer agent to issue and
         deliver to the undersigned physical certificates representing such
         shares of the Common Stock.

The undersigned requests that a Warrant representing any unexercised portion
hereof be issued, pursuant to the Warrant, in the name of the Holder and
delivered to the undersigned at the address set forth below:

Dated:
      ------------------------------------           ---------------------------
                                                            Signature of Holder

                                                     ---------------------------
                                                            Name of Holder

                                                     Address:

                                                     ---------------------------

                                                     ---------------------------

                                       17
<PAGE>
                               FORM OF ASSIGNMENT

FOR VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers all the
rights of the undersigned under the within Warrant, with respect to the number
of shares of the Common Stock covered thereby set forth hereinbelow, to:

    Name of Assignee                 Address                       No. of Shares

, and hereby irrevocably constitutes and appoints
                                                  ------------------------------
as agent and attorney-in-fact to transfer said Warrant on the books of the
within-named corporation, with full power of substitution in the premises.

Dated:
       -------------------------------------
In the presence of

--------------------------------------------
                                     Name:
                                          --------------------------------------

                                          Signature:
                                                    ----------------------------
                                          Title of Signing Officer or Agent
                                          (if any):

                                          --------------------------------------

                                     Address:

                                     -------------------------------------------

                                     -------------------------------------------

                                     Note:   The above signature should
                                             correspond exactly with the name on
                                             the face of the within Warrant.

                                       18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}]]